Ventas Inc banner

Ventas Inc
NYSE:VTR

Watchlist Manager
Ventas Inc Logo
Ventas Inc
NYSE:VTR
Watchlist
Price: 87.57 USD 3.39% Market Closed
Market Cap: $41.6B

Ventas Inc
Cash Equivalents

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Ventas Inc
Cash Equivalents Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
Ventas Inc
NYSE:VTR
Cash Equivalents
$741.1m
CAGR 3-Years
82%
CAGR 5-Years
12%
CAGR 10-Years
30%
Welltower Inc
NYSE:WELL
Cash Equivalents
$5B
CAGR 3-Years
100%
CAGR 5-Years
27%
CAGR 10-Years
30%
Omega Healthcare Investors Inc
NYSE:OHI
Cash Equivalents
$27m
CAGR 3-Years
-55%
CAGR 5-Years
-30%
CAGR 10-Years
18%
Healthcare Realty Trust Inc
NYSE:HR
Cash Equivalents
$26.2m
CAGR 3-Years
-25%
CAGR 5-Years
-26%
CAGR 10-Years
7%
Physicians Realty Trust
NYSE:DOC
Cash Equivalents
$467.5m
CAGR 3-Years
87%
CAGR 5-Years
60%
CAGR 10-Years
3%
C
CareTrust REIT Inc
NYSE:CTRE
Cash Equivalents
$198m
CAGR 3-Years
147%
CAGR 5-Years
60%
CAGR 10-Years
33%
No Stocks Found

Ventas Inc
Glance View

Ventas Inc., a titan within the realm of real estate investment trusts (REITs), has established itself as a cornerstone in the healthcare real estate sector. Built upon a foundation of strategic agility and a keen eye for demographic trends, the company adeptly acquires, owns, and manages a diversified portfolio of properties. Ventas primarily focuses on senior housing and healthcare facilities, capitalizing on the increasing demand fueled by an aging population. This concerted focus on highly resilient sectors allows Ventas to generate stable and growing cash flows, driven by long-term leasing agreements with healthcare operators. The strategic configuration of their portfolio, which spans medical office buildings, life science centers, and hospitals, ensures a balance between growth and defensive attributes, enabling the company to navigate economic fluctuations with poise. The company's revenue model is tightly interwoven with its vast network of tenants, who possess solid credit profiles and operate under long-term, triple-net leases. These leases require tenants to bear the brunt of property operating expenses, cushioning Ventas from financial volatility. Beyond simply collecting rent, Ventas actively engages in portfolio optimization through acquisitions and divestitures, always aiming to align with healthcare industry dynamics. Its astute leadership continually scouts for investment opportunities that deliver value beyond the present, underpinning ventures in emerging segments such as life sciences and outpatient facilities. This forward-thinking approach not only solidifies Ventas's position in an ever-evolving industry but also underscores its commitment to fostering sustainable growth and value creation for its stakeholders.

VTR Intrinsic Value
53.34 USD
Overvaluation 39%
Intrinsic Value
Price $87.57

See Also

What is Ventas Inc's Cash Equivalents?
Cash Equivalents
741.1m USD

Based on the financial report for Dec 31, 2025, Ventas Inc's Cash Equivalents amounts to 741.1m USD.

What is Ventas Inc's Cash Equivalents growth rate?
Cash Equivalents CAGR 10Y
30%

Over the last year, the Cash Equivalents growth was -17%. The average annual Cash Equivalents growth rates for Ventas Inc have been 82% over the past three years , 12% over the past five years , and 30% over the past ten years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett